1. 1. Bersot TP. Drug therapy for hypercholesterolemia and dyslipidemia. In: Brunton LL, editor. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th ed. McGraw-Hill, New York. 2011; 877-904.
2. 2. Fredrickson DS, Lees Rs. A system for phenotyping hyperlipoproteinemia, Circulation 1965; 31: 321 - 327
3. 3. Bersot TP. Modulation of CV function, Drug therapy for hypercholesterolemia and dyslipidemia. In: Brunton LL, editor. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 12th ed. McGraw-Hill, New York. 2011; 877-904.
4. 4. Robert. B. Baron, MD, MS. "Lipid Disorders"; CMDT 2010: 49th edition Mc Graw Hill Lange publications: 1130 - 1131
5. 5. Satoskar RS, Bhandarkar SD, Rege NN. Appetite stimulants, digestants, anti-flatulents and hypolipidemic drugs. Pharmacology and Pharmacotherapeutics 22nd edition: Popular Prakashan Pvt. Ltd., Mumbai. 2011; 571-86.